Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infection

Cell Cycle

Volumn 5, Issue 20, 2006, Pages 2396-2400

  Bouzahzah, Boumediene ^a   Nagajyothi, Fnu ^a   Desruisseaux, Mahalia S ^a   Krishnamachary, Mohan ^a   Factor, Stephen M ^a   Cohen, Alex W ^a   Lisanti, Michael P ^c   Petkova, Stefka B ^a   Pestell, Richard G ^c   Wittner, Murray ^a   Mukherjee, Shankar ^a   Weiss, Louis M ^a   Jelicks, Linda A ^a   Albanese, Chris ^b   Tanowitz, Herbert B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cell cycle regulatory proteins; Chagas' disease; Cyclin A; Cyclin D1; Cylin E; Liver; Mitogen activated protein kinase; Trypanosoma cruzi

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN E; CYCLINE; LIVER PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN P21; PROTEIN P27; PROTEIN P53; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOBLOTTING; LIVER INJURY; MOUSE; NONHUMAN; PARASITISM; PARASITOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI; VASCULITIS;

MURINAE; TRYPANOSOMA CRUZI;

EID: 33751206509     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.20.3380     Document Type: Article

References (28)

1. Tanowitz HB, Kirchhoff LV, Simon D Morris SA, Weiss LM, Wittner M. Clin Microbiol Rev 1992; 5:400-19.
2. Marinho CRF, Bucci DZ, Dagli MLZ, Bastos KRB, Grisotto MG, Sardinha LR, Baptista CRGM, Gonçalves CP, D'Império Lima MR, Álvarez JM. Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi Clone: A Model for Genetic Studies of Chagas' Disease. Infect Immun 2004; 72:2350-7.
3. Porrozzi R, Soares R, Meuser M, Guguen-Guillouzo C, Meirelles MN. Invasion and development of Trypanosoma cruzi in primary cultures of mouse embryo hepatocytes. Mem Inst Oswaldo Cruz 1997; 92:117-20.
4. Nogueira de Melo AC, Meirelles MN, Porrozzi R, Costa JD, Branquinha MH, Vermelho AB. Reduced activity of matrix metalloproteinase-9 in Trypanosoma cruzi-infected mouse embryo hepatocyte cell. Hepatology Res 1997; 28:49-56.
5. Crary GS, Albrescht JH. Expression of cyclin dependent kinase inhibitor p21 in human liver. Hepatology 1998; 28:738-43.
6. Kwon YH, Jovanovic A, Serfas MS, Tyner AL. The cdk inhibityor p21 is required for necrosis but inhibits apoptosis following toxin-induced liver injury. J Biol Chem 2000; 278:30348-55.
7. 1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C infection. Gastroenterol 2005; 128:33-42.
8. Laurent S, Starkel P, Leclercq IA, Labotte L, Maiter D, Horsmans Y. Molecular events associated with accelerated proliferative response in rat livers when partial hepatectomy is preceded by a sham operation. Eur J Clin Invest 2005; 35:120-47.
9. Osada S, Kanematsu M, Imai H, Goshima S, Sugiyama Y. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma. J Am Coll Surg 2005; 201:405-11.
10. Kitamura J, Watanabe D, Sato M. Liver regeneration, liver cancers and cyclins. J Gastroenterol Hepatol 1998; 13:96-9.
11. Nagajyothi F, Desruisseaux M, Bouzahzah B, Weiss LM, dos Santos Andrade D, Factor SM, Scherer PE, Albanese C, Lisanti MP, Tanowitz HB. Cyclin and caveolin expression in an acute model of murine chagasic myocarditis. Cell Cycle 2006; 5:107-12.
12. Rossi MA, Goncalves S, Ribeiro-dos-Santos R. Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am J Pathol 1984; 114:209-16.
13. Petkova SB, Huang H, Factor SM, Pestell RG, Bouzahzah B, Jelicks LA, Weiss LM, Douglas SA, Wittner M, Tanowitz HB. The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 2006; 31:499-511.
14. Hsu MK, Qiao L, Ho V, Zhang BH, Zhang H, Teoh N, Dent P, Farrell GC. Ethanol reduces p38 kinase activation of cyclin D1 protein expression after partial hepatectomy in rats. J Hepatol 2006; 44:375-82.
15. Svegliati-Baroni G, Ghiselli R, Marzioni M, Alvaro D, Mocchegiani F, Saccomanno S, Sisti V, Ugili L, Orlando F, Alpini G, Saba V, Benedetti A. Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats. J Hepatol 2006; 44:1158-66.
16. Leu JI, Crissey MA, Craig LE, Taub R. Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 2003; 23:1251-59.
17. Fausto, N. Liver regeneration. J Hepatol 2000; 32:19-31.
18. Schwabe RF, Bradham CA, Uehara T, Hatano E, Bennett BL, Schoonhoven R, Brenner DA. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 2003; 37:824-32.
19. Pujol MJ, Jaime M, Serratosa J, Jaumot M, Agell N, Bachs O. Differential association of p21Cip1 and p27Kip1 with cyclin E-CDK2 during rat liver regeneration. J Hepatol 2000; 33:266-74.
20. Nelsen CJ, Rickheim DG, Tucker MM, Hansen LK, Albrecht JH. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J Biol Chem 2003; 278:3656-63.
21. Albrecht JH, Hansen LK. Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ 1999; 10:397-404.
22. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999; 20:501-34.
23. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: Normal and abnormal functions. Endocrinology 2004; 145:5439-47.
24. Mukherjee S, Huang H, Petkova SB, Albanese C, Pestell RG, Braunstein VL, Christ GJ, Wittner M, Lisanti MP, Berman JW, Weiss LM, Tanowitz HB. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun 2004; 72:5274-82.
25. Weiss RH, Randour CJ. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: Effect is absent in p53-inactive cells. Cell Signal 2000; 12:413-18.
26. Weiss RH, Joo A, Randour C. p21Waf1/Cip1 is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation J Biol Chem 2000; 275:10285-90.
27. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Nat Acad Sci (USA) 1998; 95:1091-96.
28. Ilyin GP, Glaise D, Gilot D, Baffet G, Guguen-Guillouzo C. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am J Physiol Gastrointest Liver Physiol 2003; 285:G115-27.